|Year : 2019 | Volume
| Issue : 1 | Page : 13-19
Network clustering and bibliometrics of pharmacology and pharmacy research outputs published by Iranian authors
Mohammad Salehi-Marzijarani1, Seyyed-Mohammad-Taghi Ayatollahi1, Saeedeh Pourahmad1, Marziyeh Zare2, Payam Peymani2
1 Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Fars, Iran
2 Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Fars, Iran
|Date of Web Publication||28-Feb-2019|
Dr. Seyyed-Mohammad-Taghi Ayatollahi
Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Fars
Source of Support: None, Conflict of Interest: None
Objective: Evidence-based practice in medical sciences needs to publish confidential evidence that strongly depends on the research publications. This bibliometrics and network analytic study aims to evaluate the research publications of Iranian authors in pharmacology and pharmacy. Methods: Through the pharmacology and pharmacy category of Web of Science (WOS), all published articles affiliated with an Iranian researcher as an author were retrieved. Full records of retrieved articles in the WOS, including author name and affiliation, journal name, citation number, cited references, and keywords, were exported to a plain text file. Network analysis through VOSviewer was used for mapping the characteristics of the retrieved articles. All statistical analyses were done using the Microsoft Excel and SPSS version 25. Findings: The total number of Iran's publications (citations) rose from 1557 articles (10,085 citations) in 2000–2009 years to 6271 articles (77791 citations) in 2010–2018 years. Tehran University of Medical Sciences was the most productive university. The total number of RCTs rose from 82 publications in 2000–2009 to 278 publications in 2010–2018. The same numbers for systematic reviews and meta-analyses were four publications in 2000–2009 and 169 publications in 2010–2018. The five major topics of researches in pharmacology and pharmacy were drug delivery, basic pharmacology, oxidative stress, animal study, and molecular aspect of pharmacy. Conclusion: This study showed a marked increasing rate of publications and received citations by Iranians in pharmacology and pharmacy. After 2010, the rate of articles in the high-impact journals had growth. Furthermore, research articles in the highest level of evidence were more published by Iranians.
Keywords: Bibliometrics, Iran, network analysis, pharmacology, pharmacy, scientometrics
|How to cite this article:|
Salehi-Marzijarani M, Ayatollahi SM, Pourahmad S, Zare M, Peymani P. Network clustering and bibliometrics of pharmacology and pharmacy research outputs published by Iranian authors. J Res Pharm Pract 2019;8:13-9
|How to cite this URL:|
Salehi-Marzijarani M, Ayatollahi SM, Pourahmad S, Zare M, Peymani P. Network clustering and bibliometrics of pharmacology and pharmacy research outputs published by Iranian authors. J Res Pharm Pract [serial online] 2019 [cited 2020 Jan 27];8:13-9. Available from: http://www.jrpp.net/text.asp?2019/8/1/13/253210
| Introduction|| |
The term evidence is a word that scientific communities are frequently using especially in medical sciences. Evidence-based practice in several fields of the medical sciences, such as pharmacology and pharmacy, needs to published and valid evidence that strongly depends on the scientific outputs. Furthermore, scientific outputs, i.e., published articles, are considered as one of the indicators of productivity in microlevels, for example, a researcher. Simultaneously, it might help the policymakers to evaluate the productivity in macrolevels, such as a university, research center, or country. Bibliometrics is a tool that through mathematical–statistical analysis of the characteristics of the publications and citations retrieved from the indexing databases, for example, Clarivate analytics, provides a platform to evaluate the scientific outputs.
During the last decades, medical research in Iran had experienced an exponential growth rate., Pharmacology and pharmacy, as a major field of medicine, is the most productive research field for Iranian scientists. About 11% of Iran's research publications in medical and health sciences is attributable to the pharmacology and pharmacy. The landscape of the research in pharmacology and pharmacy is essential for policymakers, institutes, universities, and researchers. Although there are few numbers of bibliometrics study of Iran's researches in pharmacology and pharmacy,, there is not a report about the highest level of evidence, most-cited articles and topics, and progression of published articles in pharmacology and pharmacy.
This study aims to evaluate research publications affiliated with Iranian researchers in pharmacology and pharmacy through bibliometrics tools and network analysis. We will provide trends of published articles, received citations, publication of the highest level of evidence, networks of international collaboration, and clustering major topics in Iran's researches in pharmacology and pharmacy.
| Methods|| |
Through the pharmacology and pharmacy category of Web of Science (WOS) in the Clarivate analytics (formerly ISI), all published articles affiliated with at least an Iranian researcher as an author were retrieved. To ensure retrieving articles in the context of pharmacology and pharmacy, we limited our search strategy to the journals indexed in the Journal Citation Report (JCR) under the category of pharmacology and pharmacy. At first, the ISSN of the journals indexed in the pharmacology and pharmacy category of the WOS was extracted through the JCR 2017. Then, the search algorithm was applied in the search line as follows: IS = (“ISSN of journal 1” OR “ISSN of journal 2” OR …OR “ISSN of journal 261”) AND (AD = [Iran]). Besides, a systematized search in the PubMed on December 2018, through the same but modified search strategy used in the WOS, was conducted for extraction of the study types of the articles in pharmacology and pharmacy. Due to some misspecifications of the PubMed filters for determination of the study type, we used a comprehensive, sensitive, and combined search strategy to identify the clinical trials (CT), randomized CTs (RCTs), and systematic reviews and meta-analyses (SRMAs). The search strategy could be found in the Supplementary.[Additional file 1]
Full records of retrieved articles in the WOS, including author name and affiliation, journal name, citation number, cited references, and keywords, were exported to a plain text file. Furthermore, the rate of international collaboration was calculated. An article with affiliated authors in different countries is considered as an output of international collaboration. After data cleaning, the file was used for network analysis using the VOSviewer version 1.6.9. In the network maps, the size of the bubbles indicates some documents. The bubbles close to each other with the same colors are in the same homogeneous clusters regarding co-occurrence in the documents. The strength of the relationship is indicated by the lines connecting the bubbles.
All statistical analyses were done using the Microsoft Excel 2016 and Statistical Package for Social Sciences (IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp). Mean ± standard deviation and frequency (percent) were used for the description of quantitative and qualitative variables, respectively.
| Results|| |
Worldwide, a total of 715,919 articles were published in the 261 pharmacology and pharmacy journals indexed in the WOS. [Figure 1] shows the growth trend of publications and citations published by Iranian researchers. Iranian researchers were contributed in 7971 (1.11%) articles, with total citation of 88,412 and average citations per article of 11.08. Eighty-three articles of Iranians had received at least 83 to maximum 358 citations (H-index = 83). The total number of publications (citations) rose from 1557 articles (10085 citations) in 2000–2009 years to 6271 articles (77,791 citations) in 2010–2018 years.
|Figure 1: (Top, left) Total number of publications per year in pharmacology and pharmacy. (Top, right) Total number of citations per year. (Bottom, left) Percentage of the highest level of evidence published by Iranian authors. (Bottom, right) Ratio of SRM and Meta to CT and RCT. CT: All types of clinical trial, RCT: Randomized clinical trial, Meta: A meta-analysis, SRM: Systematic review and meta-analysis|
Click here to view
[Table 1] shows the top 10 most productive authors and universities in pharmacology and pharmacy. Tehran University of Medical Sciences was the most productive (2351 articles) and the most cited (28538 citations) university of Iran in pharmacology and pharmacy. Among the Iranian researchers, Zarrindast MR (219 articles), Dehpour AR (207 articles), and Abdollahi M (121 articles) were the authors with the highest number of publications.
|Table 1: Top 10 most productive authors, universities, and journals in pharmacology and pharmacy; and also, countries with the highest rate of collaboration with Iranian authors|
Click here to view
Two hundred and sixty-one journals, with impact factor (IF) ranged from 0 to 50.16, were indexed under the category of pharmacology and pharmacy in the WOS. Half of them had IF greater than 2.48. Just 14 journals were not indexed in the PubMed. Iranian journals indexed in the WOS were DARU Journal of Pharmaceutical Sciences (IF = 2.66), Iranian Journal of Basic Medical Sciences (IF = 1.51), and Iranian Journal of Pharmaceutical Research (IF = 1.37). All of the three journals were indexed in the PubMed. About 25% (2010 out of 7971) of the articles with an Iranian researcher was published in Iran J Pharm Res and Iran J Basic Med Sci. [Table 1] shows the top 10 journals with a large number of articles published by Iranian researchers.
The number of articles in the top 10 journals in pharmacology and pharmacy rose from 18 articles until 2009 to 86 articles after 2010 [Table 2]. However, 86.54% of the published articles in the top journals had an Iranian researcher as the first author; about 77% of them were published in J Control Release (the Netherlands, IF = 7.87) and Aliment Pharm Ther (England, IF = 7.35).
|Table 2: Total number of articles published in the top 10 journals of pharmacology and pharmacy by Iranian authors|
Click here to view
[Table 3] shows the top 10 most-cited articles in pharmacology and pharmacy by Iranian authors. Eight articles had published with Iranians as the first authors. The most-cited article was about the phenoxyl radicals of dietary flavonoids and other polyphenolics published in the toxicology (IF = 3.26) in 2002. It had an Iranian, Sabzevari et al., as the second author and received 358 citations. The most recent article in the list of top 10 most-cited article was entitled “Antioxidant activity, phenol and flavonoid contents of 13 citrus species peels and tissues” by Ghasemi et al. published in the Pak J Pharm Sci in 2009 that received 193 citations.
|Table 3: Top 10 most-cited articles in pharmacology and pharmacy by the Iranian authors|
Click here to view
Publication of the highest level of evidence
After 1990, Iranian authors published 526 of all types of CTs and 1081 of all types of review articles (RAs). The total number of RCTs rose from 82 publications in 2000–2009 to 278 publications in 2010–2018. The same numbers for SRMs were four publications in 2000–2009 and 169 publications in 2010–2018. The ratio of SRMs to CTs has converged to 1 since 2015. For the first time in 2017 and 2018, the number of SRMs and MAs has surpassed the RCTs. [Figure 1] (bottom) shows the percentage of the highest level of evidence and also the ratio of SRMs and MAs to CTs and RCTs published by Iranian authors.
Coauthorship map of authors in [Figure 2] (bottom, right) revealed 5 clusters of 31 authors with minimum of 50 articles that they collaborate. Each bubble indicates an author, and the links connecting the bubbles indicate collaboration in at least one publication. [Figure 2] (bottom, left) shows the network map of universities with at least 100 publications in the pharmacology and pharmacy. Tehran University of Medical Sciences (TUMS, 2351 articles) followed by the Shahid Beheshti University of Medical Sciences (1164 articles) and Islamic Azad University (1031 articles) are the most productive universities listed in [Table 1]. Based on the H-index, TUMS had the highest level of H-index (H = 58), followed by the Mashhad University of Medical Sciences (H = 49) and Tabriz University of Medical Sciences (H = 43).
|Figure 2: Network analysis of published researches in pharmacology and pharmacy, (Top, left) Co-authorship map of Iranian with the other countries, (Top, right) Co-occurrence map of the most frequent keywords used in articles published by Iranian authors, (Bottom, left) Co-authorship map of the universities with more than 100 published articles in pharmacology and pharmacy, (Bottom, right) Co-authorship map of the authors with minimum 50 published articles|
Click here to view
Iranian authors had the most collaboration with USA (243 articles, 3.05%) followed by England (212 articles, 2.66%) and Canada (150 articles, 1.88%). The network of an international collaboration of Iranian authors is mapped in [Figure 2] (top, left); and also, countries with the highest rate of collaboration with Iranian authors are listed in [Table 1].
Out of the 30151 unique keywords, the top 5 most frequent keywords in the articles were in vitro(648 times), mice (639 times), oxidative stress (630 times), rat (526 times), and apoptosis (516 times). The five clusters of major topics, denoted by the green, blue, red, purple, and yellow colors, based on the most commonly used terms in the researches related to the pharmacy in the pharmacy and pharmacology field were mapped in [Figure 2] (top, right). Red-colored cluster represented terms related to the drug delivery topic such as “in vitro,” “gene delivery,” or “design;” purple-colored cluster represented terms related to basic pharmacology (antioxidant activity) such as “anti-bacterial,” “essential oil,” or “chemical composition;” green-colored cluster represented terms related to oxidative stress such as “liver,” “diabetes,” or “lipid peroxidation;” blue-colored cluster represented terms related to animal study such as “rat” or “mice;” and yellow-colored cluster represented terms related to molecular aspect of pharmacy such as “apoptosis,” “expression,” and “cancer.”
| Discussion|| |
The present study is a bibliometrics and network analysis of the research articles published by Iranian authors in the field of pharmacology and pharmacy. This study showed a marked increasing rate of publications and received citations by Iranians in pharmacology and pharmacy. Furthermore, after 2010, the rate of articles in the high-impact journals had a growth. Also, during the recent decade, research articles in the highest level of evidence were more published by Iranians.
Quality of researches in pharmacology and pharmacy affiliated with Iranian researchers is improving. The increasing rate of received citations (rose from 10,085 citations in 2000–2009 to 77,791 in 2010–2018) and some articles published in the high-impact journals (rose from 18 articles until 2009 to 86 after 2010) could be considered as indicators of the research quality. This result is in line with the progression of the other fields of medical sciences in Iran.,
Zarrindast MR, Dehpour AR, and Abdollahi M were the top 3 authors that produced the highest number of published articles. The top 3 authors based on the H-index were Hosseinzadeh H, Zarrindast MR, and Dehpour AR. Like the previous studies, TUMS was the most productive regarding a total number of published articles (2351 articles), the total number of received citations (28538), and highest H-index (H = 58).,,
Iranian researchers in pharmacology and pharmacy had more collaboration with the USA, England, and Canada. Conducting researches with the international collaborations is needed to keep moving forward in the science and technology.,
Evidence is not the same. RCTs and SRMs of the RCTs are gold standards in the evidence-based medicine. They are on the top level of evidence hierarchy. The rate of publishing the highest level of evidence, for example, SRM, CTs, and RCTs in pharmacology and pharmacy is growing during the recent decades. Increasing the number of SRMs could be considered as good news for practitioners in pharmacology and pharmacy. However, they are strongly dependent on the CTs and especially RCTs as the inputs. Neglecting production of high-quality original research in the highest level of evidence, for example, RCTs can harm the evidence-based pharmacology and pharmacy over time. In general, CTs are time-consuming and need more cost and expertise. It seems that researchers tended to do SRMs that request lower cost and time, but with more scientific credits such as citation and improving H-index. Over time, this fast way to produce high-quality evidence with fewer resources makes the pharmacology and pharmacy in Iran to be more dependent, hence vulnerable to the CTs as original data published by other countries.
Network clustering indicates the five distinctive clusters of authors with minimum 50 published articles. In the previous studies, it was mentioned that Iranian authors did not tend to expand their research networks. Furthermore, this issue exists among high-level researchers. Expanding the research network could improve the visibility of researches and also provide opportunities for learning or teaching experiences.,
Most frequent keywords in the articles were in vitro, mice, oxidative stress, rat, and apoptosis. The five major topics of researches in pharmacology and pharmacy were drug delivery, basic pharmacology, oxidative stress, animal study, and molecular aspect of pharmacy. The previous researches did not explore the topics in the published articles in pharmacology and pharmacy.
Our study has some limitations and strengths. A comprehensive search strategy used in the most popular indexing databases, Clarivate analytics, and PubMed, and providing a report about the highest level of evidence published by Iranians are considered as the strengths. It is worth mentioning that there are potential articles published in the journals indexed in the other databases, for example, Scopus, or the journals in different categories of the sciences, for example, chemistry. Furthermore, all of the indexing databases have some weaknesses regarding the limited coverage of all literature in several fields of the science. Therefore, retrieved articles in the present study might underestimate the whole literature in the pharmacology and pharmacy. It might be mentioned as the limitation of the study.
In conclusion, published articles by Iranian authors in pharmacology and pharmacy are growing progressively. Its growth is regarding quantity and quality.
| Authors' Contribution|| |
Mohammad Salehi-Marzijarani and Payam Peymani provided the idea and study design, Mohammad Salehi-Marzijarani is responsible for statistical analysis, Marziyeh Zare provided the data and technical assistance, and Seyyed-Mohammad-Taghi Ayatollahi and Saeedeh Pourahmad supervised the study. Mohammad Salehi-Marzijarani and Payam Peymani drafted the manuscript, and all authors critically reviewed the manuscript, providing suggestions for revision where neccessary. All authors reviewed and approved the final version of the paper.
The authors wish to thank Mr. H. Argasi at the Research Consultation Center (RCC) of Shiraz University of Medical Sciences for his invaluable assistance in editing this manuscript.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ 1996;312:71-2.
Wiedenmayer K, Summers RS, Mackie CA, Gous AG, Everard M, Tromp D, et al
. Developing Pharmacy Practice: A Focus on Patient Care. Geneva, Switzerland: World Health Organisation and International Pharmaceutical Federation; 2006.
Hood W, Wilson C. The literature of bibliometrics, scientometrics, and informetrics. Scientometrics 2001;52:291-314.
Kharabaf S, Abdollahi M. Science growth in iran over the past 35 years. J Res Med Sci 2012;17:275-9.
Mansoori P. 50 years of Iranian clinical, biomedical, and public health research: A bibliometric analysis of the Web of Science Core Collection (1965-2014). J Glob Health 2018;8:020701.
Mesgarpour B, Etemadi A, Fotouhi A, Kebriaeezadeh A, Younesian M. The trend of pharmaceutical research in Iran compared to Middle East and North Africa: A scientometrics study. Health Information Management. 2009;6(2):141-51.
Shekofteh M, Karimi M, Kazerani M, Zayeri F, Rahimi F. Co-authorship patterns and networks in pharmacology and pharmacy in Iran. Int J Inf Sci Manage 2017;15:1-13.
2017 Journal Impact Factor, Journal Citation Reports (Clarivate Analytics, 2018).
van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010;84:523-38.
Galati G, Sabzevari O, Wilson JX, O'Brien PJ. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 2002;177:91-104.
Ghasemi K, Ghasemi Y, Ebrahimzadeh MA. Antioxidant activity, phenol and flavonoid contents of 13 citrus species peels and tissues. Pak J Pharm Sci 2009;22:277-81.
Rodríguez A, Nieto MJ, Santamaría L. International collaboration and innovation in professional and technological knowledge-intensive services. Ind Innov 2018;25:408-31.
Abdollahi M. Perspective of pharmaceutical sciences in Iran; jobs remaining. Daru 2011;19:80-2.
Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med 2016;21:125-7.
Toklu HZ. Promoting evidence-based practice in pharmacies. Integr Pharm Res Pract 2015;4:127-31.
Kao RT. The challenges of transferring evidence-based dentistry into practice. J Evid Based Dent Pract 2006;6:125-8.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3]